A De Gasperi
Overview
Explore the profile of A De Gasperi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbosa F, Aseni P, Vertemati M, Becchetti C, Airoldi A, De Gasperi A, et al.
Cardiovasc Intervent Radiol
. 2025 Jan;
48(3):351-361.
PMID: 39789254
Purpose: This study assesses the efficacy and safety of Portal Vein Recanalization with Intrahepatic Portosystemic Shunt (PVR-TIPS) in non-cirrhotic patients with chronic portal vein occlusion (CPVO), cavernomatous transformation, and symptomatic...
2.
Mazza E, Prosperi M, Panzeri M, Limuti R, Nichelatti M, De Gasperi A
Transplant Proc
. 2017 May;
49(4):677-681.
PMID: 28457370
The aims of this study were to define in a cohort of 310 liver transplant recipients, the incidence of post-liver transplantation (LT) non-carbapenem-resistant Klebsiella pneumoniae (CRKP) and CRKP infections, pre-...
3.
Pastorello E, Schroeder J, Veronese S, Pravettoni V, De Gasperi A, Cantoni S, et al.
Eur Ann Allergy Clin Immunol
. 2015 Mar;
47(2):58-61.
PMID: 25781196
Introduction: From the literature, patients with a history of anaphylaxis to hymenoptera venom and positive specific IgE have shown a correlation between elevated tryptase levels and two clinical situations: systemic...
4.
5.
Grossi P, Dalla Gasperina D, Barchiesi F, Biancofiore G, Carafiello G, De Gasperi A, et al.
Transplant Proc
. 2011 Aug;
43(6):2463-71.
PMID: 21839295
Use of various induction regimens, of novel immunosuppressive agents, and of newer prophylactic strategies continues to change the pattern of infections among solid organ transplant (SOT) recipients. Although invasive fungal...
6.
De Gasperi A, Corti A, Mazza E, Prosperi M, Amici O, Bettinelli L
Transplant Proc
. 2009 May;
41(4):1256-9.
PMID: 19460532
Acute liver failure (ALF) is defined as a severe, sudden liver dysfunction that induces encephalopathy and coagulopathy (prothrombin time [PT/INR] > 1.5) within 26 weeks of the onset of symptoms...
7.
Rossetti O, Soldano S, Aseni P, Colombo V, Roselli E, De Gasperi A, et al.
Transplant Proc
. 2007 Aug;
39(6):1820-2.
PMID: 17692621
To satisfy the increasing requests for renal grafts, elderly donors are increasingly accepted for kidney transplant at many centers. The main unresolved question is the long-term effect on graft survival...
8.
De Gasperi A
G Ital Nefrol
. 2006 Oct;
23 Suppl 36:S61-8.
PMID: 17068731
Fulminant liver failure is characterized by massive acute Hepatocyte dysfunction associated with severe coagulopathy, acute hyperdynamic circulatory failure and hepatic encephalopathy. According to the more recent classification, which takes into...
9.
De Gasperi A
Minerva Anestesiol
. 2006 May;
72(6):489-94.
PMID: 16682921
Recombinant activated factor VII (rFVIIa, Novoseven, Novo Nordisk, Denmark) was introduced as a prohemostatic agent in the early 80s: the only indication approved in USA by Food and Drug Administration...
10.
De Gasperi A, Amici O, Mazza E, Garrone F, Sciascia A, Corti A
Transplant Proc
. 2006 May;
38(3):815-7.
PMID: 16647480
No abstract available.